Home › Parasomnias › NCT04588233
Melatonin Adolescent Research Study
Understanding the Impact of Melatonin Use on Adolescent Functioning: A Pilot and Feasibility Trial of the Melatonin Adolescent Research Study (MARS)
Who can join
Ages 13 to 17 · All sexes
Full eligibility criteria
Inclusion Criteria: * Self-identified sleep difficulties (e.g., difficulty falling asleep, staying asleep, or premature waking resulting in short or disrupted sleep). * Ages 13 to 17 years old * Able to understand, read, and write in English * Melatonin naive Exclusion Criteria: * Obesity * Use of psychiatric medication * Drug(s), or supplements known to affect sleep * History of head injury or concussion with loss of consciousness \>1 minute * Daily consumption of \>1 caffeinated beverage * Risk for any organic sleep disorder (e.g., obstructive sleep apnea, restless leg syndrome)
About the study
The present study will use a within-person, randomized cross-over experimental design to test the effects of exogenous melatonin supplementation on the sleep and daytime functioning of typically developing adolescents with short or disrupted sleep of behavioral origins (i.e., difficulty falling asleep, staying asleep, or premature waking resulting in short or disrupted sleep not attributed to an organic sleep condition).
What is being tested
- Melatonin (dietary supplement)
- Placebo (other)
Sponsor: Loma Linda University · Participants: 80 · Started: Sep 15, 2021
Contact the study team
- Brooke Iwamoto · Phone: 909-558-7412
Official record on ClinicalTrials.gov — NCT04588233
Locations in the U.S.
| California | Loma Linda U, Loma Linda Loma Linda University, Loma Linda (Not yet recruiting) |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.